Liria Mitzuko Fajardo-Yamamoto is a clinical researcher at Sanoviv Medical Institute; in 2020, she worked in Sanoviv’s Triage Department on preventing Covid-19 spread among the worker community. Mitzuko graduated from Panamerican University Medical School in 2014 and earnt her Master’s degree in Biomedicine and Bionanotechnology in 2018 from the Center for Scientific Research and Higher Education at Ensenada (CICESE), Mexico. Her research interests are cancer, public health, and preventive and lifestyle medicine. In 2015 she was a sub-investigator in CREDENCE, a Phase 3 Clinical Trial recruiting patients to explore the effects of canagliflozin in diabetic patients with established nephropathy (28431754DNE3001). From 2015 to 2019, she was a professor of several courses at the National Autonomous University of Mexico, Panamerican University, and Xochicalaco University; and in 2021 was recognized by CICESE for her support as a volunteer in Mexico’s Public Health System during the Covid-19 pandemic.